| Active substance | Etanercept |
| Holder | Pfizer |
| Status | Closed |
| Indication | Psoriatic arthritis in children aged 12-17 years |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 26/01/2016 |
Enbrel®
Last updated on
| Active substance | Etanercept |
| Holder | Pfizer |
| Status | Closed |
| Indication | Psoriatic arthritis in children aged 12-17 years |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 26/01/2016 |